Betancur, Paola A.
Abraham, Brian J.
Yiu, Ying Y.
Willingham, Stephen B.
Khameneh, Farnaz
Zarnegar, Mark
Kuo, Angera H.
McKenna, Kelly
Kojima, Yoko
Leeper, Nicholas J.
Ho, Po
Gip, Phung
Swigut, Tomek
Sherwood, Richard I.
Clarke, Michael F.
Somlo, George
Young, Richard A. http://orcid.org/0000-0001-8855-8647
Weissman, Irving L.
Article History
Received: 20 May 2016
Accepted: 27 January 2017
First Online: 5 April 2017
Competing interests
: I.L.W. is co-founder, holds equity and is a Director and consultant of Forty Seven, Inc, a company developing CD47 antibody therapies. All other authors declare no competing financial interests.